Abstract #1834

Comparison of detection rate of prostate cancer between mpMRI guided in-bore biopsy and routine TRUS biopsy

Sujeet K Mewar¹, Sanjay Sharma², Ekta Dhamijia ³, Sanjay Thulkar³, Sridhar Panaiyadiyan⁴, Pradeep Kumar¹, S. Senthil Kumaran¹, Virendra Kumar¹, S. Datta Gupta⁵, Rajeev Kumar⁴, and Naranamangalam R Jagannathan¹

¹Department of NMR and MRI Facility, All India Institute of Medical Sciences, New Delhi, India, ²Department of Radio-diagnosis, All India Institute of Medical Sciences, New Delhi, India, ³Department of Radio-diagnosis, IRCH, All India Institute of Medical Sciences, New Delhi, India, ⁴Department of Urology, All India Institute of Medical Sciences, New Delhi, India, ⁵Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

The present study demonstrated the role of mpMRI guided in-bore biopsy for detection of prostate cancer (PCa). Patients were recruited based on PSA > 4 ng/ml and abnormal DRE. The PCa detection rate between the two groups of patients, namely 25 patients (Group I) who underwent in-bore biopsy and 73 patients (Group II) who underwent TRUS biopsy were compared. The PCa detection rate of in-bore targeted biopsy was 52% compared to 34.3% for TRUS biopsy. Our data also indicated that in-bore MR targeted biopsy significantly increased the detection rate of PCa when compared with the standard 12 core TRUS biopsy.

This abstract and the presentation materials are available to members only; a login is required.

Join Here